Veterinary Diagnostics

VolitionRx Reports Progress in Diagnostics Pipeline, Including Feline Lymphoma Manuscript Submission Tied to $5M Milestone

VolitionRx Reports Progress in Diagnostics Pipeline, Including Feline Lymphoma Manuscript Submission Tied to $5M Milestone

VolitionRx provided a corporate update highlighting clinical and commercial progress, including a feline lymphoma manuscript submission linked to a $5 million milestone payment and licensing discussions with over a dozen global diagnostic companies.

May 27, 2026
VolitionRx Reports High Accuracy in Feline Cancer Blood Test, Unlocking $5M Milestone

VolitionRx Reports High Accuracy in Feline Cancer Blood Test, Unlocking $5M Milestone

VolitionRx's Nu.Q Vet prototype assay shows 97% specificity in detecting feline lymphoma, advancing a liquid biopsy for cats and unlocking a $5 million contractual milestone upon peer-reviewed publication.

May 6, 2026